查詢結果分析
相關文獻
- Malignancy After Heart Transplantation
- 移植後淋巴增生性疾病之病例用藥探討
- 出院後心臟移植病人的困擾及其處置
- Heart Rate Variability as an Assessment of Acute Rejection after Heart Transplantation
- A Patient of Primary Hyperparathyroidism with Full-Blown Bone Changes Simulating Malignancy
- 心臟移植後患者性問題初探
- Cardiorespiratory Response of Heart Transplantation Recipients to Exercise in the Early Postoperative Period
- Restrictive Cardiomyopathy in a Patient with Primary (AL) Cardiac Amyloidosis: Should Heart Transplantation be Performed﹖-- A Case Report and Review
- Clinical Experience with Ventricular Endomyocardial Biopsy in Chinese Heart Transplant Patients: A Four-Year Survey of 1,208 Consecutive Procedures
- 臺大醫院心臟移植百例之反省
頁籤選單縮合
題 名 | Malignancy After Heart Transplantation=心臟移植病人之移植後惡性腫瘤 |
---|---|
作 者 | 陳柏霖; 張效煌; 陳沂名; 賴曉亭; 施俊哲; 翁仁崇; 謝婉珍; 楊安航; | 書刊名 | Journal of the Chinese Medical Association |
卷 期 | 72:11 2009.11[民98.11] |
頁 次 | 頁588-593+CA109 |
分類號 | 416.262 |
關鍵詞 | 心臟移植; 惡性腫瘤; 移植後淋巴增生性疾病; Heart transplantation; malignancy; Post-transplant lymphoproliferative disorder; |
語 文 | 英文(English);英文(English) |
英文摘要 | Background: The purpose of this study was to assess the incidence and type of malignancies after heart transplantation at a medical institute in Taiwan. Methods: From January 1987 to December 2008, a total of 66 patients who survived more than 30 days after transplantation were enrolled in this study. Results: Of the 66 heart transplant recipients, 8 (12.1%) post-transplant malignancies were diagnosed: 5 post-transplant lymphoproliferative diseases (PTLD), 1 prostate cancer, 1 lung cancer, and 1 squamous cell carcinoma of the cheek. The clinical presentations were diverse, and the diagnoses were confirmed by biopsy. Only 1 patient died of PTLD and subsequent multiple organ failure. Conclusion: Cancer is a limiting factor for long-term survival after heart transplantation. The most common type in this study was PTLD. Early detection and aggressive treatment results in good response and preserves the allograft. |
本系統中英文摘要資訊取自各篇刊載內容。